We partner with the media to inform the public of the global human crisis.
March 23, 2018INDIVIOR RESPONDS TO COURT RULING IN ANDA LITIGATION AND ANNOUNCES INTENTION TO APPEAL...
March 22, 2018Annual Report & Accounts 2017 and Annual General Meeting 2018...
March 1, 2018SUBLOCADE™ (Buprenorphine Extended-Release) is Now Available as First and Only Monthly Injectable Buprenorphine in the U.S. to Treat Patients with Moderate to Severe Opioid Use Disorder...
February 28, 2018Indivior Chief Medical Officer Ponni Subbiah, M.D., Provides Testimony Before the US House of Representatives’ Energy and Commerce Subcommittee on Health Hearing on Combating the Opioid Crisis: Helping Communities Balance Enforcement and Patient Safety...
February 15, 2018Indivior PLC Full Year 2017 Financial Results...
Global Media Contacts
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline